Cargando…
Comparison between different treatment regimens of vascular targeting drug to malignant pleural effusion in patients with lung cancer: A Bayesian network meta-analysis
The presence of malignant pleural effusion in lung cancer patients often suggests a poor prognosis. We plan to investigate which regimen of vascular targeting drug is preferable to control the malignant pleural effusion in such patients. METHODS: Two investigators dependently searched and screened f...
Autores principales: | Huang, Peng, Guo, Zhi-Kai, Xue, Zhan-Tu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662921/ https://www.ncbi.nlm.nih.gov/pubmed/37478250 http://dx.doi.org/10.1097/MD.0000000000034386 |
Ejemplares similares
-
Diagnostic value of pleural fluid SMRP, CA125, MMP-7, and MMP-9 in malignant pleural effusion
por: Han, Gaohua, et al.
Publicado: (2023) -
Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis
por: Hu, Yongqi, et al.
Publicado: (2022) -
The clinical efficacy of traditional Chinese medicine in the treatment of malignant pleural effusion: A protocol of systematic review and meta-analysis
por: Lin, Zhen, et al.
Publicado: (2020) -
Combination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion
por: Qi, Nan, et al.
Publicado: (2016) -
Pleural small cell carcinoma with massive pleural effusion: A case report
por: Jang, Jong Geol, et al.
Publicado: (2019)